Skip to main content
. Author manuscript; available in PMC: 2020 Aug 5.
Published in final edited form as: Circ Cardiovasc Interv. 2020 Feb 5;13(2):e008494. doi: 10.1161/CIRCINTERVENTIONS.119.008494

Table 6.

Multivariate Analysis for Time to TVF at Entire Follow-Up

Characteristic HR (95% CI) P Value
Balloon-stent balloon use 0.84 (0.63–1.13) 0.24
Age 1.00 (0.98–1.02) 0.78
Diabetes mellitus 1.09 (0.81–1.46) 0.57
>1 target lesions 1.60 (1.12–2.29) 0.0097
Years since CABG 1.03 (1.00–1.05) 0.0382
History of CHF 1.26 (0.94–1.69) 0.12
PCI for ACS 1.17 (0.87–1.58) 0.30
Presence of thrombus 0.83 (0.55–1.25) 0.37
Baseline TIMI-3 flow 0.56 (0.40–0.78) 0.0006
EPD used 0.99 (0.72–1.36) 0.96

TVF is a composite of cardiac death, target vessel myocardial infarction, and target vessel revascularization. ACS indicates acute coronary syndrome; CABG, coronary artery bypass grafting; CHF, congestive heart failure; EPD, embolic protection device; HR, hazard ratio; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction; and TVF, target vessel failure.